Physician profile
Aisha Aslam
NPI 1184944886
$2,801.53
in general payments reported to CMS, 2019-2025
20 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $230 · 2022: $95.25 · 2023: $147 · 2024: $695 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $519.95 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $430.22 | 2019-2025 | Breztri, Airsupra |
| Amgen INC. | $327.03 | 2019-2024 | Krystexxa |
| Abbott Laboratories | $266.77 | 2023-2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $218.73 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.03 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $147.26 | 2019-2025 | Mounjaro |
| Madrigal Pharmaceuticals | $124.16 | 2024 | Rezdiffra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.77 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $114.30 | 2025 | Gvoke Hypopen |
| Ethicon INC. | $99.06 | 2025 | Monarch Platform |
| Pfizer INC. | $61.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $57.70 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $44.56 | 2019 | |
| Amarin Pharma, INC. | $26.42 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.01 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $18.59 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.46 | 2019 | |
| Philips North America LLC | $15.37 | 2019 | |
| Shire North American Group INC | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.